Customized pachymetric guided epithelial debridement for corneal collagen cross linking

被引:46
作者
Kymionis, George D. [1 ,2 ]
Diakonis, Vasilios F. [1 ]
Coskunseven, Efekan [3 ]
Jankov, Mirco [4 ]
Yoo, Sonia H. [2 ]
Pallikaris, Ioannis G. [1 ]
机构
[1] Univ Crete, Dept Med, Inst Vis & Opt, Iraklion, Greece
[2] Miami Univ, Miller Sch Med, Bascom Palmer Eye Inst, Oxford, OH 45056 USA
[3] World Eye Hosp, Istanbul, Turkey
[4] Univ Beogradu, Dept Med, Beogradu, Serbia
来源
BMC OPHTHALMOLOGY | 2009年 / 9卷
关键词
Riboflavin; Corneal Epithelium; Keratoconus; Endothelial Cell Density; Topographic Steepen;
D O I
10.1186/1471-2415-9-10
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Backround: We describe a modified method for deepitheliazation prior to corneal cross linking (CXL). The technique may overcome the current corneal pachymetric limitation parameter (over 400 microns) that is necessary for the safety of the procedure without affecting the overall benefits. Methods: In a series of two patients, with inferior topographic steepening and regional thinning (less than 400 microns corresponding to the area of corneal steepening), CXL after customized epithelial removal was performed. Results: There were no intra- or postoperative adverse events seen by the nine month follow up examination. Stabilization of the corneal ectasia was observed up to nine months post-costumized pachymetric-guided epithelial removal. Conclusion: The technique of customized pachymetric-guided epithelial removal is easy to perform and may overcome the limitations of the preoperative corneal pachymetry expanding the application of the procedure in patients with regional corneal thinning.
引用
收藏
页数:4
相关论文
共 9 条
[1]   Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis [J].
Hafezi, Farhad ;
Kanellopoulos, John ;
Wiltfang, Rainer ;
Seiler, Theo .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (12) :2035-2040
[2]   Therapeutic cross-linking of the cornea using Riboflavin/UVA [J].
Koller, T. ;
Seiler, T. .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (09) :700-706
[3]  
Kolozsvári L, 2002, INVEST OPHTH VIS SCI, V43, P2165
[4]   Corneal cross-linking-induced stromal demarcation line [J].
Seiler, Theo ;
Hafezi, Farhad .
CORNEA, 2006, 25 (09) :1057-1059
[5]   Increased resistance of crosslinked cornea against enzymatic digestion [J].
Spoerl, E ;
Wollensak, G ;
Seiler, T .
CURRENT EYE RESEARCH, 2004, 29 (01) :35-40
[6]   Safety of UVA-riboflavin cross-linking of the cornea [J].
Spoerl, Eberhard ;
Mroehen, Michael ;
Sliney, David ;
Trokel, Stephen ;
Seiler, Theo .
CORNEA, 2007, 26 (04) :385-389
[7]   Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro [J].
Wollensak, G ;
Spoerl, E ;
Reber, F ;
Seiler, T .
EYE, 2004, 18 (07) :718-722
[8]   Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro [J].
Wollensak, G ;
Spörl, E ;
Reber, F ;
Pillunat, L ;
Funk, R .
OPHTHALMIC RESEARCH, 2003, 35 (06) :324-328
[9]   Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus [J].
Wollensak, G ;
Spoerl, E ;
Seiler, T .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (05) :620-627